Cytogenetic and molecular abnormalities in Waldenström's macroglobulinemia patients: correlations and prognostic impact.
Sign Up to like & getrecommendations! Published in 2021 at "American journal of hematology"
DOI: 10.1002/ajh.26339
Abstract: While Waldenström macroglobulinemia (WM) is characterized by an almost unifying mutation in MYD88, clinical presentation at diagnosis and response to therapy can be widely different among WM patients. Current prognostic tools only partially address this… read more here.
Keywords: waldenstr macroglobulinemia; impact; cytogenetic molecular; molecular abnormalities ... See more keywords
Accreditation strategy for rare somatic molecular abnormalities detected or quantified by polymerase chain reaction: GBMHM recommendations.
Sign Up to like & getrecommendations! Published in 2019 at "Annales de biologie clinique"
DOI: 10.1684/abc.2019.1498
Abstract: In 2020, accreditation of molecular tests according to ISO 15189 is a requirement for all French medical laboratories. For many years, the GBMHM group (French Group of Molecular Biologists in Hematology) supports this approach through… read more here.
Keywords: accreditation strategy; accreditation; rare somatic; strategy rare ... See more keywords
Treatment of Gastrointestinal Stromal Tumors (GISTs): A Focus on Younger Patients
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14122831
Abstract: Simple Summary Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the gastrointestinal tract. GISTs mainly develop in older adults, and the median age of diagnosis is 60–65 years. The incidence of GISTs… read more here.
Keywords: stromal tumors; molecular abnormalities; tumors gists; gists young ... See more keywords